Navigation Links
Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
Date:6/16/2008

LYON, France and SWIFTWATER, Pa., June 16 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today its commitment to donate 60 million doses of H5N1 vaccine to the World Health Organization (WHO) over 3 years for the establishment of an H5N1 vaccine global stockpile.

"The H5N1 virus is currently circulating in some of the poorest regions of the world and an outbreak of pandemic influenza would most likely hit populations living in areas with limited access to vaccines. This donation of H5N1 vaccine aims to address the needs of those most vulnerable populations," said Wayne Pisano, President and Chief Executive Officer of sanofi pasteur. "In addition to supporting the efforts of governments, it is essential that industry collaborates with international organizations such as WHO, the Bill and Melinda Gates Foundation and other global health players. This is the best way to build a stockpile of vaccines for developing nations, ready to be deployed on the ground in the event of a pandemic flu outbreak," added Pisano.

Sanofi Pasteur's leadership position in developing and producing influenza vaccines places the company at the forefront of readiness against the threat of pandemic influenza. The company is committed to addressing current and future public health needs by investing in a robust research and development program and in an ambitious seasonal and pandemic influenza vaccine production plan.

Each year since 2004, sanofi pasteur produced millions of doses of H5N1 avian influenza vaccine, both in France and in the United States. In April 2007, the U.S. Food and Drug Administration (FDA) licensed sanofi pasteur's H5N1 vaccine, the first avian influenza vaccine for humans in the U.S.

Sanofi Pasteur recently conducted clinical trials with a novel, proprietary adjuvant aimed at dramatically reducing the amount of antigen needed to elicit a protective immune response to the H5N1 strain currently ide
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
5. World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cancer Research
6. Globus Medical Raises $110 Million in Series E Financing Round
7. Atritech Announces Completion of a $22 Million Equity Financing
8. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
9. EntreMed Raises $20 Million to Support Clinical Development Program
10. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
11. Isis Announces $1.2 Million Award to Its Ibis Subsidiary to Expand Influenza Detection Capabilities and Enable Large-Scale Influenza Transmission Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014  BioScrip ® , Inc. (NASDAQ: BIOS ) ... Executive Officer, will present at the Bank of America Merrill Lynch ... , Date: , , , Wednesday, December 3, 2014 , ... , , , Location: , , , Boca Raton Resort ... Inc. BioScrip, Inc. is a leading national ...
(Date:11/26/2014)... -- Zynerba Pharmaceuticals , Inc., a specialty pharmaceutical ... cannabinoid treatments, today announced that the company will present ... The conference will be held December 2 to 3, ... York . Zynerba,s Chairman and CEO, Armando ... December 2. To listen to a webcast ...
(Date:11/26/2014)... 26, 2014  Aridis Pharmaceuticals, Inc., a biopharmaceutical ... for infectious diseases, announced today the addition of ... key opinion leader in the areas of pneumonia ... Founder and Chief Executive Officer, ... Opal,s extensive experience investigating bacterial toxins and key ...
Breaking Medicine Technology:Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 2Aridis Pharmaceuticals Appoints Dr. Steven Opal to Scientific Advisory Board 3
... WASHINGTON, Aug. 30, 2011 Public Citizen filed a petition ... the FDA should revise its rules that bar generic drug ... drug makers should be allowed to ask the FDA to ... to patients who take their drugs. Reporters developing a story ...
... LAKE FOREST, Ill., Aug. 29, 2011 Hospira, Inc. (NYSE: ... medication delivery company, today announced that it will host an ... 2011. F. Michael Ball, Hospira,s chief executive officer, and several ... event. A streaming audio webcast of the event, ...
Cached Medicine Technology:
(Date:11/26/2014)... 26, 2014 Bunion Bootie, the newest ... in an early celebration of the early holiday shopping ... offered at the promotional price of $29.95 each (normally ... addition to any automatic discounts applied when buying more ... website for complete details. It’s simple: purchasing more ...
(Date:11/26/2014)... Louisiana Back Institute, leaders of ... minimally invasive spine surgery, announces today the addition ... growing provider network of orthopedic spine surgeons and ... the network’s continuing success providing the most innovative ... who are suffering from orthopedic spine conditions and ...
(Date:11/26/2014)... November 26, 2014 Sonoran Vein ... recently received the Distinguished Preceptorship Award from ... her role in the advancement of nurse practitioners. ... an individual who had made a significant contribution ... The American Association of Nurse Practitioners (AANP) is ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Youngsters who enter puberty ... study suggests. Early puberty was linked with a ... self-image and high anxiety levels, according to the researchers. ... as conflict with family and peers, and having friends ... found. Although the study found an association between ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
Breaking Medicine News(10 mins):Health News:Bunion Bootie Temporarily Lowering Prices for Holiday Shopping, Starting Today! 2Health News:Louisiana Back Institute Welcomes Dr. K. Samer Shamieh into Medical Provider Network 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Early Puberty Linked to Increased Risk of Depression in Teens 2Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2
... is estimated at around $2.5 trillion per annum, which ... per annum. A radical shift in food consumption pattern ... ,In markets, especially in the developed world, with a ... rapidly increasing. Besides, the emerging health-conscious newer generation globally ...
... Yale Cancer Center is proud to announce the launch of ... Public Radio. Beginning on National Cancer Survivors Day , June ... p.m. on Sunday evenings and feature the latest information on ... Miller, M.D. , ,Cancer Answers is co-hosted by ...
... of therapeutic genes, which will have major implications for ... the 10th Annual Meeting of the American Society of ... gene expression is crucial to the success of gene ... being employed to engineer cells for therapeutic factor production, ...
... gene to diabetes patients using nanoparticles, was presented today at ... Gene Therapy (ASGT) in Seattle. ,Type 1 or ... producing pancreatic -cells. As a result of the loss of ... fine blood vessels and nerve endings leading to debilitating symptoms. ...
... today the start of the EASE (Exhale Airway Stents ... explore an investigational treatment that may offer a ... emphysema. The study focuses on an experimental procedure called ... for trapped air to escape with the goal of ...
... poised to earn the dubious distinction of becoming a country ... better emergency facilities for heart patients could save lives, ... (WHO) reports, India is likely to become the heart attack ... have been spreading like an epidemic and have been affecting ...
Cached Medicine News:Health News:Nutrient-rich Dairy Beverages an Emerging Market 2Health News:Yale Cancer Center Answers: A New Weekly Radio Progam on WNPR 2Health News:New Platform for Regulating Expression of Therapeutic Genes Unveiled 2Health News:Novel Delivery Method of Insulin Gene to Combat Juvenile Diabetes Developed 2Health News:Airway Bypass Treatment for Emphysema - Study 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: